started · updated
Iran lawmakers call for prosecutor intervention over hemophilia drug shortage
Salman Eshaghi, spokesperson for the Parliament's Health and Treatment Commission, has called for the country's Prosecutor General to intervene regarding the supply of vital medications for patients with rare and incurable diseases. The request specifically addresses the shortage of Factor XIII, a critical medication for hemophilia patients.
Eshaghi noted that while a shipment of recombinant Factor XIII has been imported and delivered to a distribution company, patients have been unable to access it for approximately one month. He attributed the delay to financial and credit disputes, as well as unresolved issues regarding drug price differences.
The lawmaker criticized what he termed self-sanctioning, stating that foreign sanctions did not prevent the drug from entering the country. He expressed concern that changes in currency policies and administrative disagreements between government agencies are preventing life-saving medicine from reaching those in need, potentially leading to irreversible consequences for patient health.